Performance overview
Value at beginning of month: $140,475.45
Value at end of month: $150,941.05
Month over month change: +7.45%
Total IRR: 18.21%
Related indices, monthly change
NASDAQ: +7.42%
IVV (iShares Core S&P 500): +6.94%
IBB (iShares NASDAQ Biotechnology Index): +9.21%
MXI (iShares Global Materials): +10.34%
VEGI (iShares MSCI Global Agriculture Producers): +9.25%
ICLN (iShares Clean Energy): +7.25%
Individual performances
Intrexon had a particularly strong performance due to an announced partnership for cannabinoid production as well as positive clinical trial news for a microbe-based diabetes treatment. Kraig Biocraft Laboratories had a second great month in a row as well. The only company that had a really bad month was Arcadia Biosciences, who were down over 40% thanks to having to raise additional funds.
Changes made to index
None.
You can view the index here.
Allocation as of June 29, 2019
